Shamali Abeyagunawardena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shamali Abeyagunawardena has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Asiri Samantha Abeyagunawardena
University of Peradeniya, Peradeniya, Sri Lanka.
2 shared publications - Shenal Thalgahagoda
Teaching Hospital Peradeniya
2 shared publications - Umeshi Ishanthika Karunadasa
University of Peradeniya, Postgraduate Institute of Science, University of Peradeniya
2 shared publications - Amila Jayasinghe
University of Peradeniya
1 shared publication - Andra Hennadige Heshan Malinga Jayaweera
Sri Lanka College of Paediatricians, Colombo, Sri Lanka
1 shared publication - Asoka Sameera Bandara Wasala
University of Peradeniya
1 shared publication
Latest Publications
- Open Access
- 31 October 2021
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2021, 1-3
Expanded Dengue Syndrome: A Case of Subarachnoid Haemorrhage, Cranial Diabetes Insipidus, and Haemophagocytic Lymphohistiosis
Dengue fever is a mosquito-borne viral infection common in tropical countries with increasing incidence. The clinical manifestations can range from asymptomatic or mild infection to multiorgan failure. The latter is also called “Expanded dengue syndrome,” and it carries a high rate of mortality and morbidity. Intensive care management of such complicated cases is a challenging task for the treating physician, which requires intense monitoring and a multidisciplinary approach for decision making. We report an atypical case of an expanded dengue syndrome presented with subarachnoid haemorrhage associated with moderate thrombocytopenia, cranial diabetes insipidus, and haemophagocytic lymphohistiosis in a young healthy female patient.
- 31 October 2021
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2021, 1-3
Open AccessExpanded Dengue Syndrome: A Case of Subarachnoid Haemorrhage, Cranial Diabetes Insipidus, and Haemophagocytic Lymphohistiosis
Dengue fever is a mosquito-borne viral infection common in tropical countries with increasing incidence. The clinical manifestations can range from asymptomatic or mild infection to multiorgan failure. The latter is also called “Expanded dengue syndrome,” and it carries a high rate of mortality and morbidity. Intensive care management of such complicated cases is a challenging task for the treating physician, which requires intense monitoring and a multidisciplinary approach for decision making. We report an atypical case of an expanded dengue syndrome presented with subarachnoid haemorrhage associated with moderate thrombocytopenia, cranial diabetes insipidus, and haemophagocytic lymphohistiosis in a young healthy female patient.
- Open Access
- 1 October 2021
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2021, 1-6
Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity
Introduction. Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that interact with macrophages and T-lymphocytes, causing degranulation and inflammation with cytokine release. It is a life-threatening condition that has many trigger factors and is most commonly caused by medicines. Case Presentation. A 71-year-old male was admitted with a fever of five days duration associated with cellulitis, for which he had been treated with clindamycin and flucloxacillin before admission. He was a diagnosed patient with hypertension and dyslipidemia five years ago. After taking the antibiotics, he had developed generalized itching followed by urticaria suggesting an allergic reaction. Therefore, he was admitted to the hospital. After admission, he developed an ischaemic-type chest pain associated with autonomic symptoms and shortness of breath. An immediate ECG was taken that showed ST-segment depressions in the chest leads V4V6, confirmed by a repeat ECG. Troponin I was 8ng/mL. Acute management of ACS was started, and prednisolone 10mg daily dose was given. After complete recovery, the patient was discharged with aspirin, clopidogrel, atorvastatin, metoprolol, losartan, isosorbide mononitrate, and nicorandil. Prednisolone 10mg daily dose was given for five days after discharge. Conclusion. In immediate hypersensitivity, with persistent cardiovascular instability, Kounis syndrome should be considered, and an electrocardiogram and other appropriate assessments and treatments should be initiated. Prompt management of the allergic reaction and the ACS is vital for a better outcome of Kounis syndrome.
- 1 October 2021
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2021, 1-6
Open AccessKounis Syndrome Secondary to Medicine-Induced Hypersensitivity
Introduction. Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that interact with macrophages and T-lymphocytes, causing degranulation and inflammation with cytokine release. It is a life-threatening condition that has many trigger factors and is most commonly caused by medicines. Case Presentation. A 71-year-old male was admitted with a fever of five days duration associated with cellulitis, for which he had been treated with clindamycin and flucloxacillin before admission. He was a diagnosed patient with hypertension and dyslipidemia five years ago. After taking the antibiotics, he had developed generalized itching followed by urticaria suggesting an allergic reaction. Therefore, he was admitted to the hospital. After admission, he developed an ischaemic-type chest pain associated with autonomic symptoms and shortness of breath. An immediate ECG was taken that showed ST-segment depressions in the chest leads V4V6, confirmed by a repeat ECG. Troponin I was 8ng/mL. Acute management of ACS was started, and prednisolone 10mg daily dose was given. After complete recovery, the patient was discharged with aspirin, clopidogrel, atorvastatin, metoprolol, losartan, isosorbide mononitrate, and nicorandil. Prednisolone 10mg daily dose was given for five days after discharge. Conclusion. In immediate hypersensitivity, with persistent cardiovascular instability, Kounis syndrome should be considered, and an electrocardiogram and other appropriate assessments and treatments should be initiated. Prompt management of the allergic reaction and the ACS is vital for a better outcome of Kounis syndrome.
- Open Access
- 4 June 2021
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 50 (2) , 334-337
Transition from paediatric to adult care: an emerging challenge
- 4 June 2021
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 50 (2) , 334-337
Open AccessTransition from paediatric to adult care: an emerging challenge
- Open Access
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 84-87
A possible case of levamisole-induced pauci-immune focal necrotising and crescentic glomerulonephritis
Sri Lanka Journal of Child Health, 2019: 48(1): 84-87
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 84-87
Open AccessA possible case of levamisole-induced pauci-immune focal necrotising and crescentic glomerulonephritis
Sri Lanka Journal of Child Health, 2019: 48(1): 84-87
- Open Access
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 77-79
Disseminated tuberculosis following immunosuppressive therapy for nephrotic syndrome
Sri Lanka Journal of Child Health, 2019; 48(1): 77-79
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 77-79
Open AccessDisseminated tuberculosis following immunosuppressive therapy for nephrotic syndrome
Sri Lanka Journal of Child Health, 2019; 48(1): 77-79